Chemical Compound
Raltegravir potassium
CAS Registry Number
871038-72-1
Primary Record
Raltegravir potassium
- In stock
- 1,938 g
- Purity
- 99.2 %
- CAS
- 871038-72-1
Compound Identifiers & Properties
- CAS
- 871038-72-1
- PubChem CID
- 23668479
- SMILES
- CC1=NN=C(O1)C(=O)NC(C)(C)C2=NC(=C(C(=O)N2C)[O-])C(=O)NCC3=CC=C(C=C3)F.[K+]
- Canonical SMILES
- Cc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c([O-])c(=O)n2C)o1.[K+]
Names & Synonyms
- Raltegravir potassium
- Raltegravir Potassium Salt
- Isentress
- 871038-72-1
- Raltegravir
- Isentress hd
- Isentress (TN)
- Raltegravirpotassium
- RaltegravirPotassiumSalt
- Raltegravir (potassium)
- MK0518 POTASSIUM
- Potassium, Raltegravir
- MK-0518 POTASSIUM
- Raltegravir monopotassium salt
- RefChem:55965
- Raltegravir (potassium salt)
- Raltegravir potassium CRS
- Raltegravir ( K salt) API
- MFCD12031642
- MK-0518 potassium salt
- Raltegravir potassium [USAN]
- MK-0518
- C20H20FKN6O5
- CHEMBL518520
- orb1305955
- Raltegravir potassium [USAN:JAN]
- UNII-43Y000U234
- 871038-72-1 (potassium)
- C20H20FN6O5.K
- SCHEMBL15939218
- CTK8E9230
- AMY3328
- IFUKBHBISRAZTF-UHFFFAOYSA-M
- MK0518
- BCPP000092
- DTXSID501007339
- GLXC-90403
- HMS5084D19
- HY-10353AR
- Raltegravir potassium (JAN/USAN)
- RALTEGRAVIR POTASSIUM [JAN]
- BCP01757
- L000900612 POTASSIUM SALT
- MK 0518
- Raltegravir (potassium) (Standard)
- L000900612 POTASSIUM
- AN-406
- HY-10353A
- L-000900612 POTASSIUM SALT
- MK-518
- 43Y000U234
- L-000900612 POTASSIUM
- RALTEGRAVIR POTASSIUM [MART.]
- AKOS015896594
- RALTEGRAVIR POTASSIUM [USP-RS]
- RALTEGRAVIR POTASSIUM [WHO-DD]
- AC-2062
- ACN-053808
- CCG-269568
- CS-3263
- FR27670
- Raltegravir for peak identification CRS
- TRA0035437
- KS-000000A6
- potassium 4-((4-fluorobenzyl)carbamoyl)-1-methyl-2-(2-(5-methyl-1,3,4-oxadiazole-2-carboxamido)propan-2-yl)-6-oxo-1,6-dihydropyrimidin-5-olate
- Pseudourea, 2-methyl-2-thio-, sulfate
- AK326594
- AS-19171
- BR164314
- Raltegravir potassium - Bio-X trade mark
- SC-99419
- SY258338
- DUTREBIS COMPONENT RALTEGRAVIR POTASSIUM
- RALTEGRAVIR MONOPOTASSIUM SALT [MI]
- RALTEGRAVIR POTASSIUM [ORANGE BOOK]
- RALTEGRAVIR POTASSIUM [EP MONOGRAPH]
- RT-015376
- FT-0649661
- RALTEGRAVIR POTASSIUM [USP MONOGRAPH]
- X4991
- EC-000.2353
- A10775
- A25486
- D07133
- J10313
- AB01274746-01
- I06-2266
- Q27258678
- N-((4-Fluorophenyl)methyl)-1,6-dihydro-5-hydroxy-1-methyl-2-(1-methyl-1-(((5-methyl-1,3,4-oxadiazol-2-yl)carbonyl)amino)ethyl)-6-oxo-4-pyrimidinecarboxamide monopotassium salt
- potassium 4-{[(4-fluorophenyl)methyl]carbamoyl}-1-methyl-2-{2-[(5-methyl-1,3,4-oxadiazol-2-yl)formamido]propan-2-yl}-6-oxo-1,6-dihydropyrimidin-5-olate
- potassium;4-[(4-fluorophenyl)methylcarbamoyl]-1-methyl-2-[2-[(5-methyl-1,3,4-oxadiazole-2-carbonyl)amino]propan-2-yl]-6-oxopyrimidin-5-olate
- 4-Pyrimidinecarboxamide, N-((4-fluorophenyl)methyl)-1,6-dihydro-5-hydroxy-1-methyl-2-(1-methyl-1-(((5-methyl-1,3,4-oxadiazol-2-yl)carbonyl)amino)ethyl)-6-oxo-, monopotassium salt
- 4-Pyrimidinecarboxamide, N-[(4-fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-, potassium salt (1:1); 4-Pyrimidinecarboxamide, N-[(4-fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-, monopotassium salt (9CI); Isentress; MK 0518; Raltegravir potassium
- N-[(4-Fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo -4-pyrimidinecarboxamide potassium salt
- N-[(4-Fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-4-pyrimidinecarboxamide Potassium Salt
- N-[1-[4-[(4-fluorophenyl)methylcarbamoyl]-5-hydroxy-1-methyl-6-oxo-pyrimidin-2-yl]-1-methyl-ethyl]-5-methyl-1,3,4-oxadiazole-2-carboxamide
- Potassium 4-((4-fluorobenzyl)carbamoyl)-1-methyl-2-(1-methyl-1-(((5-methyl-1,3,4-oxadiazol-2-yl)carbonyl)amino)ethyl)-6-oxo-1,6-dihydropyrimidin-5-olate
- Potassium 4-[(4-fluorobenzyl)carbamoyl]-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-1,6-dihydropyrimidin-5-olate
- potassium 4-[(4-fluorophenyl)methylcarbamoyl]-1-methyl-2-[1-methyl-1-[(5-methyl-1,3,4-oxadiazole-2-carbonyl)amino]ethyl]-6-oxo-pyrimidin-5-olate
- Potassium 4-[{[(4-fluorophenyl)methyl]imino}(hydroxy)methyl]-1-methyl-2-[2-(5-methyl-1,3,4-oxadiazole-2-carboxamido)propan-2-yl]-6-oxo-1,6-dihydropyrimidin-5-olate
- Potassium 4-[{[(4-fluorophenyl)methyl]imino}(hydroxy)methyl]-1-methyl-2-{2-[(5-methyl-1,3,4-oxadiazole-2-carbonyl)amino]propan-2-yl}-6-oxo-1,6-dihydropyrimidin-5-olate
- potassium;4-[(4-fluorophenyl)methylcarbamoyl]-1-methyl-2-[1-methyl-1-[(5-methyl-1,3,4-oxadiazole-2-carbonyl)amino]ethyl]-6-oxo-pyrimidin-5-olate